GB201107197D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB201107197D0
GB201107197D0 GBGB1107197.4A GB201107197A GB201107197D0 GB 201107197 D0 GB201107197 D0 GB 201107197D0 GB 201107197 A GB201107197 A GB 201107197A GB 201107197 D0 GB201107197 D0 GB 201107197D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1107197.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CXR Biosciences Ltd
Original Assignee
CXR Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CXR Biosciences Ltd filed Critical CXR Biosciences Ltd
Priority to GBGB1107197.4A priority Critical patent/GB201107197D0/en
Publication of GB201107197D0 publication Critical patent/GB201107197D0/en
Priority to PCT/GB2012/050934 priority patent/WO2012146933A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1107197.4A 2011-04-28 2011-04-28 Compounds Ceased GB201107197D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1107197.4A GB201107197D0 (en) 2011-04-28 2011-04-28 Compounds
PCT/GB2012/050934 WO2012146933A1 (en) 2011-04-28 2012-04-27 Cyprodinil for use in medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1107197.4A GB201107197D0 (en) 2011-04-28 2011-04-28 Compounds

Publications (1)

Publication Number Publication Date
GB201107197D0 true GB201107197D0 (en) 2011-06-15

Family

ID=44202958

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1107197.4A Ceased GB201107197D0 (en) 2011-04-28 2011-04-28 Compounds

Country Status (2)

Country Link
GB (1) GB201107197D0 (en)
WO (1) WO2012146933A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103800315B (en) * 2012-11-09 2016-12-21 中国中化股份有限公司 Compound of benzene nitriles is as the application preparing antitumor drug
WO2014110574A1 (en) 2013-01-14 2014-07-17 Incyte Corporation Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
KR102403306B1 (en) 2013-01-15 2022-06-02 인사이트 홀딩스 코포레이션 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors
US9556197B2 (en) 2013-08-23 2017-01-31 Incyte Corporation Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
EP3040073B1 (en) * 2013-08-27 2020-07-08 Sinochem Corporation Applications of substituent benzyloxy group containing ether compounds for preparing antitumor drugs
US9580418B2 (en) 2014-07-14 2017-02-28 Incyte Corporation Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
US9822124B2 (en) 2014-07-14 2017-11-21 Incyte Corporation Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors
CN105267214B (en) * 2014-07-21 2019-04-30 沈阳化工研究院有限公司 N- heteroaryl amino benzenes compounds are as the application for preparing anti-tumor drug
WO2016196244A1 (en) 2015-05-29 2016-12-08 Incyte Corporation Pyridineamine compounds useful as pim kinase inhibitors
AR105967A1 (en) 2015-09-09 2017-11-29 Incyte Corp SALTS OF A PIM QUINASA INHIBITOR
TW201718546A (en) 2015-10-02 2017-06-01 英塞特公司 Heterocyclic compounds useful as PIM kinase inhibitors
US11690847B2 (en) 2016-11-30 2023-07-04 Case Western Reserve University Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof
JP7300394B2 (en) 2017-01-17 2023-06-29 ヘパリジェニックス ゲーエムベーハー Protein kinase inhibition to promote liver regeneration or reduce or prevent hepatocyte death
WO2018145080A1 (en) 2017-02-06 2018-08-09 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase activity
JP7178360B2 (en) 2017-04-07 2022-11-25 ケース ウエスタン リザーブ ユニバーシティ Inhibitors of short-chain dehydrogenase activity for treating coronary artery disorders
AR113922A1 (en) 2017-12-08 2020-07-01 Incyte Corp LOW DOSE COMBINATION THERAPY FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS
EP3773726A1 (en) * 2018-04-09 2021-02-17 Moshe Giladi Treating tumors with ttfields and an aurora kinase inhibitor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1570738A1 (en) * 2004-02-12 2005-09-07 Bayer CropScience S.A. Fungicidal composition comprising a pyridylethylbenzamide derivative and a compound capable of inhibiting the spores germination or mycelium growth by acting on different metabolic routes
BRPI1011066A2 (en) * 2009-05-20 2017-03-21 Cylene Pharmaceuticals Inc "pyrazolopyrimidines and related heterocycles as kinase inhibitors

Also Published As

Publication number Publication date
WO2012146933A1 (en) 2012-11-01

Similar Documents

Publication Publication Date Title
IL286152A (en) Substituted imidazopyridinyl-aminopyridine compounds
IL233154A0 (en) Compounds
GB201109763D0 (en) Compounds
GB201106395D0 (en) Compounds
PT2710018T (en) New compounds
GB201118652D0 (en) New compounds
ZA201306857B (en) Mesogen-containing compounds
GB201106799D0 (en) Novel compounds
GB201107325D0 (en) Novel compounds
GB201118654D0 (en) New compounds
LT2776436T (en) New compounds
GB201122139D0 (en) Compounds
GB201107197D0 (en) Compounds
GB201106814D0 (en) New compounds
EP2717694A4 (en) Novel compounds
HK1191326A1 (en) Azaspirodecanone compounds
EP2771012A4 (en) New compounds
GB201110938D0 (en) Compounds
GB201105659D0 (en) Compounds
HK1191946A1 (en) New hexahydropyrroloimidazolone compounds
GB201118613D0 (en) Compounds
GB201120805D0 (en) Compounds
GB201119745D0 (en) Compounds
GB201119703D0 (en) Compounds
GB201115829D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)